ArticleWorld journal of oncology2019

Low Body Mass Index Is an Independent Prognostic Factor in Patients With Non-Small Cell Lung Cancer Treated With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor.

Seigo Minami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.